Taken together, these findings clearly indicate that the above factors are key components of the NF‐κB signal transduction pathway in NP cells, which are likely to play key roles in the pathogenesis of IDD and represent new pharmacological targets. The gene discussed is NFKB1; the disease is intervertebral disk degenerative disorder.